Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Zardavas

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Breast (Edinburgh, Scotland)|August 10, 2015
Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015Dimitrios Zardavas, Tamer M Fouad, Martine Piccart
Breast Cancer Research : BCR|September 6, 2014
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical dataDimitrios Zardavas, Wayne A Phillips, Sherene Loi
Nature Reviews. Clinical Oncology|September 13, 2018
Progress in adjuvant systemic therapy for breast cancerNoam F Pondé, Dimitrios Zardavas, Martine Piccart
Current Opinion in Oncology|September 28, 2012
Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancerDimitrios Zardavas, Ivana Bozovic-Spasojevic, Evandro de Azambuja
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Nature Reviews. Clinical Oncology|April 22, 2015
Clinical management of breast cancer heterogeneityDimitrios Zardavas, Alexandre Irrthum, Charles Swanton, et al.
Expert Review of Anticancer Therapy|October 15, 2016
Targeted adjuvant therapy in breast cancerDimitrios Zardavas, Konstantinos Tryfonidis, Theodora Goulioti, et al.
Breast (Edinburgh, Scotland)|April 28, 2017
New agents for endocrine resistance in breast cancerChristian Maurer, Samuel Martel, Dimitrios Zardavas, et al.
Cancer Treatment Reviews|September 20, 2016
Endocrine treatment in breast cancer: Cure, resistance and beyondKonstantinos Tryfonidis, Dimitrios Zardavas, Benita S Katzenellenbogen, et al.
Plos One|March 15, 2017
Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USAFelipe Ades, Christelle Senterre, Dimitrios Zardavas, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|August 10, 2015
Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015Dimitrios Zardavas, Tamer M Fouad, Martine Piccart
Breast Cancer Research : BCR|September 6, 2014
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical dataDimitrios Zardavas, Wayne A Phillips, Sherene Loi
Nature Reviews. Clinical Oncology|September 13, 2018
Progress in adjuvant systemic therapy for breast cancerNoam F Pondé, Dimitrios Zardavas, Martine Piccart
Current Opinion in Oncology|September 28, 2012
Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancerDimitrios Zardavas, Ivana Bozovic-Spasojevic, Evandro de Azambuja
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Nature Reviews. Clinical Oncology|April 22, 2015
Clinical management of breast cancer heterogeneityDimitrios Zardavas, Alexandre Irrthum, Charles Swanton, et al.
Expert Review of Anticancer Therapy|October 15, 2016
Targeted adjuvant therapy in breast cancerDimitrios Zardavas, Konstantinos Tryfonidis, Theodora Goulioti, et al.
Breast (Edinburgh, Scotland)|April 28, 2017
New agents for endocrine resistance in breast cancerChristian Maurer, Samuel Martel, Dimitrios Zardavas, et al.
Cancer Treatment Reviews|September 20, 2016
Endocrine treatment in breast cancer: Cure, resistance and beyondKonstantinos Tryfonidis, Dimitrios Zardavas, Benita S Katzenellenbogen, et al.
Plos One|March 15, 2017
Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USAFelipe Ades, Christelle Senterre, Dimitrios Zardavas, et al.
Pageof 5